ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 090,99
-0,78%
Dow Jones
43 659,27
0,53%
DAX
22 425,93
0,73%
Brent Oil
74,315
0,28%
Bitcoin
94 274,77
-2,08%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. MBX Biosciences Inc (MBX) Cours

MBX Biosciences Inc

MBX Biosciences Inc (MBX)

My Foodie Box Ltd
Microbix Biosystems Inc
10,80
-0,08
( -0,74% )
Mis à jour : 19:57:33
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
10,80
Prix Achat
10,71
Prix Vente
10,79
Volume échangé
43 158
10,26 Fourchette du Jour 11,0433
8,631 Plage de 52 semaines 26,19
Cap du marché
360,908M
Clôture Veille
10,88
Ouverture
10,63
Dernière Transaction
1
@
10.75
Dernière heure de transaction
19:58:02
Volume financier
US$ 458 307
VWAP
10,6193
Volume moyen (3 m)
310 443
Actions en circulation
33 417 418
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-11,06
Bénéfice par action (BPA)
-0,97
Chiffre d'affairess
-
Bénéfice net
-32,56M

À propos de MBX Biosciences Inc

MBX Biosciences is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. Our PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time... MBX Biosciences is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. Our PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. We are advancing a pipeline of novel candidates for endocrine and metabolic disorders. Our lead product candidate, MBX 2109, is a parathyroid hormone peptide prodrug that is designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism, or HP. We designed MBX 2109 to treat the underlying pathophysiology of HP by providing a continuous, infusion-like exposure to parathyroid hormone, or PTH, with convenient once-weekly administration. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.mbxbio.com.
Siège social
Wilmington, Delaware, USA
Fondé
-
MBX Biosciences Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker MBX. Le dernier cours de clôture d'MBX Biosciences était de US$10,88. Au cours de la dernière année, les actions de MBX Biosciences ont été négociées dans une fourchette de prix de US$ 8,631 à US$ 26,19.

MBX Biosciences compte actuellement 33 417 418 actions en circulation. La capitalisation boursière d'MBX Biosciences est de US$363,58 million. MBX Biosciences a un ratio cours/bénéfice (ratio PE) de -11.06.

MBX Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 Février 2025
MBX (-0,74%)

Form 8-K - Current report
Edgar (US Regulatory)
07 Janvier 2025
MBX (-0,74%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
07 Novembre 2024
MBX (-0,74%)

Form 8-K - Current report
Edgar (US Regulatory)
07 Novembre 2024
MBX (-0,74%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.272.564102564110.5312.309910.2521281511.14578156CS
40.676.61401776910.1314.238.63132677810.87248995CS
12-9.62-47.11067580820.4224.198.63131044315.27408949CS
26-12.2-53.04347826092326.198.63122643617.49820613CS
52-12.2-53.04347826092326.198.63122643617.49820613CS
156-12.2-53.04347826092326.198.63122643617.49820613CS
260-12.2-53.04347826092326.198.63122643617.49820613CS

MBX - Frequently Asked Questions (FAQ)

What is the current MBX Biosciences share price?
The current share price of MBX Biosciences is US$ 10,80
How many MBX Biosciences shares are in issue?
MBX Biosciences has 33 417 418 shares in issue
What is the market cap of MBX Biosciences?
The market capitalisation of MBX Biosciences is USD 363,58M
What is the 1 year trading range for MBX Biosciences share price?
MBX Biosciences has traded in the range of US$ 8,631 to US$ 26,19 during the past year
What is the PE ratio of MBX Biosciences?
The price to earnings ratio of MBX Biosciences is -11,06
What is the reporting currency for MBX Biosciences?
MBX Biosciences reports financial results in USD
What is the latest annual profit for MBX Biosciences?
The latest annual profit of MBX Biosciences is USD -32,56M
What is the registered address of MBX Biosciences?
The registered address for MBX Biosciences is THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the MBX Biosciences website address?
The website address for MBX Biosciences is www.mbxbio.com.
Which industry sector does MBX Biosciences operate in?
MBX Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
STECSantech Holdings Limited
US$ 1,82
(179,87%)
110,65M
YYAIConnexa Sports Technologies Inc
US$ 1,2294
(92,06%)
128M
PEPGPepGen Inc
US$ 2,55
(86,13%)
104,03M
RETOReTo Eco Solutions Inc
US$ 0,651
(60,38%)
68,39M
GSUNGolden Sun Health Technology Group Ltd
US$ 3,92
(47,92%)
2,66M
THTarget Hospitality Corporation
US$ 5,2102
(-44,34%)
9,9M
NKLANikola Corporation
US$ 0,2549
(-32,92%)
37,88M
CHSNChanson International Holding
US$ 0,26
(-29,04%)
4,43M
BOXLBoxlight Corporation
US$ 2,21
(-28,71%)
460,7k
STAIScanTech AI Systems Inc
US$ 2,3501
(-28,57%)
3,46M
NVDANVIDIA Corporation
US$ 134,52
(0,07%)
158,62M
PLTRPalantir Technologies Inc
US$ 93,5292
(-7,72%)
138,27M
YYAIConnexa Sports Technologies Inc
US$ 1,225
(91,38%)
128,02M
CNEYCN Energy Group Inc
US$ 0,2718
(11,12%)
111,38M
STECSantech Holdings Limited
US$ 1,83
(181,41%)
110,65M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
MBX
MBX Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces